ONTOGENETIC DEVELOPMENT OF LYMPHOCYTES
ONTOGENETIC DEVELOPMENT OF LYMPHOCYTES
批准号:
3176440
负责人:
ULRICH G HAMMERLING
金额:
$26.92万
依托单位国家:
美国
项目类别:
财政年份:
1984
资助国家:
美国
项目状态:
已结题
起止时间:
1984-04-01 至 1992-03-31
关键词:
B lymphocyte RNA affinity chromatography antibody autoradiography biological polymorphism cell differentiation clone cells crosslink electrofocusing flow cytometry gel electrophoresis gel filtration chromatography gene expression genetic manipulation genetic translation helper T lymphocyte high performance liquid chromatography histochemistry /cytochemistry histocompatibility antigens histocompatibility gene hybridomas immunochemistry immunogenetics interferons interleukin 2 isoantibody leukocyte activation /transformation linkage mapping lymphocyte macrophage membrane activity mitomycins mixed tissue /cell culture molecular cloning monoclonal antibody nuclease phosphorylation radiotracer suppressor T lymphocyte surface antigens thymus tumor necrosis factor alpha
中文摘要
Ly-6异体抗原群是细胞表面的一个例子
英文摘要
The Ly-6 group of alloantigens is one example of cell-surface
antigen systems which are encoded by multigene families. At
least five distinct Ly-6 antigens named Ly-6A, B, C, D and Th B
have been identified by us and others. Decisive progress in the
biochemical and serological characterization of these antigens
strongly supports our working hypothesis of close structural
relationships between the Ly-6 antigens. Direct support is
rendered by analysis at the DNA level with the first Ly-6 cDNA
probe available, which has confirmed the existence of multiple
cross-hybridizing Ly-6DNA sequences in the mouse genome. The
other breakthrough was the demonstration in several
laboratories, including ours, that Ly-6.A antigens are important
modulators allied with T cell activation, thus providing for the
first time clues regarding the physiological role of Ly-6 for
lymphocytes.
In view of these new developments our project on the
immunogenetics of Ly-6 will be redefined as follows: we will
1) Analyse the Ly-6A and related genes in detail,
2) Continue cellular immunological studies of Ly-6 using normal
cells and cloned cell lines to test the hypothesis that Ly-6 is a
signal modulator in cellular activation,
3) Continue the biochemical characterization of Ly-6 proteins
to determine glycosylation and phosphorylation status and their
form of plasma membrane association,
4) Look for Ly-6 involvement in multimolecular complexes on
the cell surface,
5) Following the finding that Ly-6A is selectively induced by
interferon, study modulation of Ly-6 antigen and gene expression
by lymphokines on T cell, B cells and NK cells and correlate this
with functional responses.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
New Pathway of Vitamin A Action.
-
批准号:7469998
-
项目类别:
-
资助金额:$33.93万
-
财政年份:2005
-
负责人:ULRICH G HAMMERLING
-
依托单位:
New Pathway of Vitamin A Action.
-
批准号:6967756
-
项目类别:
-
资助金额:$34.76万
-
财政年份:2005
-
负责人:ULRICH G HAMMERLING
-
依托单位:
New Pathway of Vitamin A Action.
-
批准号:7122785
-
项目类别:
-
资助金额:$36.13万
-
财政年份:2005
-
负责人:ULRICH G HAMMERLING
-
依托单位:
New Pathway of Vitamin A Action.
-
批准号:7245146
-
项目类别:
-
资助金额:$34.63万
-
财政年份:2005
-
负责人:ULRICH G HAMMERLING
-
依托单位:
New Pathway of Vitamin A Action.
-
批准号:7633156
-
项目类别:
-
资助金额:$33.93万
-
财政年份:2005
-
负责人:ULRICH G HAMMERLING
-
依托单位:
NOVEL RECEPTORS OF VITAMIN A IN THE CYTOPLASM
-
批准号:6230486
-
项目类别:
-
资助金额:$33.99万
-
财政年份:2001
-
负责人:ULRICH G HAMMERLING
-
依托单位:
NOVEL RECEPTORS OF VITAMIN A IN THE CYTOPLASM
-
批准号:6710501
-
项目类别:
-
资助金额:$8.15万
-
财政年份:2001
-
负责人:ULRICH G HAMMERLING
-
依托单位:
NOVEL RECEPTORS OF VITAMIN A IN THE CYTOPLASM
-
批准号:6967564
-
项目类别:
-
资助金额:$33.05万
-
财政年份:2001
-
负责人:ULRICH G HAMMERLING
-
依托单位:
NOVEL RECEPTORS OF VITAMIN A IN THE CYTOPLASM
-
批准号:6495839
-
项目类别:
-
资助金额:$4.84万
-
财政年份:2001
-
负责人:ULRICH G HAMMERLING
-
依托单位:
NOVEL RECEPTORS OF VITAMIN A IN THE CYTOPLASM
-
批准号:6590998
-
项目类别:
-
资助金额:$8.15万
-
财政年份:2001
-
负责人:ULRICH G HAMMERLING
-
依托单位:
NOVEL RECEPTORS OF VITAMIN A IN THE CYTOPLASM
-
批准号:7107131
-
项目类别:
-
资助金额:$31.39万
-
财政年份:2001
-
负责人:ULRICH G HAMMERLING
-
依托单位:
NOVEL RECEPTORS OF VITAMIN A IN THE CYTOPLASM
-
批准号:7233945
-
项目类别:
-
资助金额:$33.34万
-
财政年份:2001
-
负责人:ULRICH G HAMMERLING
-
依托单位:
NOVEL RECEPTORS OF VITAMIN A IN THE CYTOPLASM
-
批准号:6514847
-
项目类别:
-
资助金额:$33.82万
-
财政年份:2001
-
负责人:ULRICH G HAMMERLING
-
依托单位:
NOVEL RECEPTORS OF VITAMIN A IN THE CYTOPLASM
-
批准号:6633906
-
项目类别:
-
资助金额:$33.82万
-
财政年份:2001
-
负责人:ULRICH G HAMMERLING
-
依托单位:
NOVEL RECEPTORS OF VITAMIN A IN THE CYTOPLASM
-
批准号:7417904
-
项目类别:
-
资助金额:$33.47万
-
财政年份:2001
-
负责人:ULRICH G HAMMERLING
-
依托单位:
VITAMIN A AS PRECURSOR OF INTRACELLULAR SECOND MESSENGER
-
批准号:2185059
-
项目类别:
-
资助金额:$32.64万
-
财政年份:1993
-
负责人:ULRICH G HAMMERLING
-
依托单位:
VITAMIN A AS PRECURSOR OF INTRACELLULAR SECOND MESSENGER
-
批准号:3307092
-
项目类别:
-
资助金额:$32.83万
-
财政年份:1993
-
负责人:ULRICH G HAMMERLING
-
依托单位:
VITAMIN A AS PRECURSOR OF INTRACELLULAR SECOND MESSENGER
-
批准号:2185060
-
项目类别:
-
资助金额:$33.55万
-
财政年份:1993
-
负责人:ULRICH G HAMMERLING
-
依托单位:
VITAMIN A AS PRECURSOR OF INTRACELLULAR SECOND MESSENGER
-
批准号:2185058
-
项目类别:
-
资助金额:$34.55万
-
财政年份:1993
-
负责人:ULRICH G HAMMERLING
-
依托单位:
LIPID GROWTH FACTOR FOR NORMAL AND MALIGNANT B CELLS
-
批准号:2093521
-
项目类别:
-
资助金额:$24.73万
-
财政年份:1989
-
负责人:ULRICH G HAMMERLING
-
依托单位:
国内基金
海外基金
登录
查看更多内容
RNA m6A修饰通过调控FDX1介导的铜死亡参与补阳还五汤抗脑缺血再灌注损伤作用机制的研究
-
批准号:2026JJ81091
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:刘亮
-
依托单位:
免标记CRISPR-RNA适配体与门逻辑分子诊断新方法研究
-
批准号:2026JJ50010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:应站明
-
依托单位:
基于合成生物标志物的超多重RNA数字化检测平台用于肿瘤精准诊断和分期评估
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:程子译
-
依托单位:
RACK1乳酸化调控RNA损伤—核糖体应激通路介导卵巢癌铂耐药的分子机制和干预研究
-
批准号:82673836
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2026
-
负责人:杨毕康
-
依托单位:
Dead-box解旋酶DDX23通过调控RNA高级结构促进肝癌细胞恶性生物学行为的分子机制研究
-
批准号:JCZRLH202600588
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
基于基因编辑技术解析丹酚酸B靶向SAMHD1调控心肌线粒体RNA稳态干预心衰的分子机制研究
-
批准号:JCZRLH202601084
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
RNA 结合蛋白HuR与VEGF-D联合调控舌鳞癌侵袭及转移机制的研究
-
批准号:2026JJ80684
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:龚攀
-
依托单位:
24-脱氢胆固醇还原酶DHCR24作为RNA结合蛋白调控PIM1翻译促进肾透明细胞癌进展的功能机制研究
-
批准号:82606550
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.00万元
-
批准年份:2026
-
负责人:宁昊
-
依托单位:
糖基化RNA-lncRNA-GLY1通过激活ITGB1通路促进HBV相关肝癌转移的机制
-
批准号:2026JJ81914
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:周克兵
-
依托单位:
X连锁RNA结合基序蛋白通过上调CXCL8分泌诱导巨噬细胞M2型极化促进结直肠癌奥沙利铂耐药
-
批准号:2026JJ80231
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:曹婷
-
依托单位: